Fulgent Genetics, Inc. (FLGT) vs OrthoPediatrics Corp. (KIDS)

A side-by-side comparison of Fulgent Genetics, Inc. and OrthoPediatrics Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FLGT vs KIDS

growth of $100 · dividends reinvested · last 9y
FLGT +419.7% (+20.1%/yr)KIDS +19.1% (+2.0%/yr)FLGT compounded faster over this window
01k2k3k4kStart $1002019202120232025$520$119
FLGT KIDS

FLGT vs KIDS: by the numbers

  • •FLGT is the larger company ($602M vs $582M market cap).
  • •Both run net losses; KIDS's is the smaller (-15.72% vs -26.05% net margin).
  • •KIDS grew revenue faster over the past five years (23.14% vs -18.66% CAGR).

Metrics side by side

Valuation

MetricFLGTKIDS
P/S ratio1.862.30
P/B ratio0.601.69

Profitability

MetricFLGTKIDS
Gross margin35.58%73.65%
Operating margin-28.23%-9.01%
Net margin-26.05%-15.72%
ROE-8.42%-11.56%
ROIC-11.80%-4.97%

Growth (annualized)

MetricFLGTKIDS
Revenue CAGR (5Y)-18.66%23.14%
Total return CAGR (5Y)-22.38%-18.40%

Frequently asked

Which has grown faster, FLGT or KIDS?
Over the past five years, KIDS grew revenue faster — FLGT at a -18.66% CAGR versus KIDS at 23.14%.
How have FLGT and KIDS total returns compared?
Over the past 5 years, FLGT delivered -22.38% and KIDS delivered -18.40% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.